“Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU)”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S51. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/296.